ARK Genomic Revolution ETF vs Vanguard High Dividend Yield ETF — how do they compare? ARK Genomic Revolution ETF trades at $44.27, while Vanguard High Dividend Yield ETF trades at $166.47. Which is the better fit depends on your goals.
| ARKG | VYM | |
|---|---|---|
Sector | Sector/Thematic | — |
52-Week High | $44.55 | $166.14 |
52-Week Low | $24.02 | $136.63 |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VYM trades at $166.36, up 0.18% today, with a bullish technical signal from moving averages but overbought RSI readings. The ETF focuses on high dividend yield stocks, offering income appeal, though key valuation ratios like P/E and P/B are not available. Recent news highlights institutional position adjustments and discussions on its role in retirement income portfolios.
Outlook is mixed: technical indicators suggest near-term caution due to overbought conditions, while the dividend strategy supports long-term income. Risks include market volatility and yield compression. Analyst sentiment is generally positive for income-focused investors, but monitor for pullbacks.
Trailing returns across standard periods
Latest headlines on both assets
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →The advisor employs an indexing investment approach designed to track the performance of the index, which consists of common stocks of companies that pay dividends that generally are higher than average. The advisor attempts to replicate the target index by investing all, or substantially all, of the fund's assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VYM →